David H. Raulet

{{Short description|American immunologist}}

{{Use mdy dates|date=December 2024}}

{{Infobox person

| name = David H. Raulet

| image = David H. Raulet giving the 2022 Martin Meyerson Berkeley Faculty Research Lecture Not All Killers Are Bad.png

| alt =

| caption = Giving the 2022 lecture "Not All Killers Are Bad" at UC Berkeley

| birth_name =

| birth_date =

| birth_place = Buffalo, New York, US

| death_date =

| death_place =

| burial_place =

| occupation = Immunologist

| employer = University of California, Berkeley

| awards =

| spouse =

| children =

| education = {{Plainlist|

• University of Michigan
• Massachusetts Institute of Technology

}}

| signature =

| party =

}}

David H. Raulet is an American immunologist who specializes in studying the role of natural killer cells. He is a professor in the Department of Molecular and Cell Biology at the University of California, Berkeley where he also holds the Esther and Wendy Schekman Chair in cancer biology.{{Cite web|url=https://vcresearch.berkeley.edu/faculty/david-h-raulet|title=David H. Raulet {{!}} Research UC Berkeley|website=vcresearch.berkeley.edu|access-date=2020-04-01}} He was elected to the National Academy of Sciences in 2019.{{Cite web|url=http://www.nasonline.org/member-directory/members/20047191.html|title=David Raulet|website=www.nasonline.org|access-date=2020-04-01}} Raulet is also the co-founder of Dragonfly Therapeutics,{{Cite web|title=About|url=https://www.dragonflytx.com/about-us|access-date=2021-05-21|website=Dragonfly|language=en}} a company that seeks to use natural killer cells for cancer immunotherapy.